A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin.

A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin.

Evidence that selenium affects the risk of type-2 diabetes is conflicting, with observational studies and a few randomized trials showing both lower and higher risk linked to the level of selenium intake and status. We investigated the effect of selenium supplementation on the risk of type-2 diabete...

Full description

Bibliographic Details
Main Authors: Margaret P Rayman, Gabrielle Blundell-Pound, Roberto Pastor-Barriuso, Eliseo Guallar, Holger Steinbrenner, Saverio Stranges
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3446875?pdf=render

Similar Items

Similar Items